Sam Brusco, Associate Editor09.19.23
Stryker has launched PROstep MIS Lapidus, an internal fixation system to treat bunions via a minimally invasive surgical (MIS) reduction of hallux valgus deformity and subsequent fusion on the first metatarsal cuneiform joint.
PROstep MIS Lapidus features MIS joint preparation, triplanar reduction, and a three-screw construct engineered to create a tension band for biomechanical stability. The system will make its debut at the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting this week.
“This procedure can be a better option for patients who are worried about cosmetic scarring from surgery and can mitigate the potential loss of correction caused by improper bone healing,” Dr. Alastair Younger, Head of the Distal Extremities Division at the University of British Columbia, told the press. “I appreciate having a viable minimally invasive surgery option that provides surgeons and their patients more options for treating bunions.”
According to published data, PROstep MIS Lapidus brings about a 2.5% decrease in recurrence compared to open Lapidus procedures and a 9% reduction in non-union rates as a result of MIS joint preparation. The system causes 76% reduction in scar size compared to open bunion correction procedures, and has been demonstrated to cause less opioid usage post-op compared to open Lapidus procedures.
“PROstep MIS Lapidus puts the power back in our surgeon customers' hands to make the best decision for their patients,” said Patrick Fisher, VP and GM for Stryker’s Foot and Ankle business unit. “At Stryker, we're continuing to expand our surgery options to support our commitment to advancing minimally invasive foot and ankle surgery.”
PROstep MIS Lapidus features MIS joint preparation, triplanar reduction, and a three-screw construct engineered to create a tension band for biomechanical stability. The system will make its debut at the American Orthopaedic Foot & Ankle Society (AOFAS) annual meeting this week.
“This procedure can be a better option for patients who are worried about cosmetic scarring from surgery and can mitigate the potential loss of correction caused by improper bone healing,” Dr. Alastair Younger, Head of the Distal Extremities Division at the University of British Columbia, told the press. “I appreciate having a viable minimally invasive surgery option that provides surgeons and their patients more options for treating bunions.”
According to published data, PROstep MIS Lapidus brings about a 2.5% decrease in recurrence compared to open Lapidus procedures and a 9% reduction in non-union rates as a result of MIS joint preparation. The system causes 76% reduction in scar size compared to open bunion correction procedures, and has been demonstrated to cause less opioid usage post-op compared to open Lapidus procedures.
“PROstep MIS Lapidus puts the power back in our surgeon customers' hands to make the best decision for their patients,” said Patrick Fisher, VP and GM for Stryker’s Foot and Ankle business unit. “At Stryker, we're continuing to expand our surgery options to support our commitment to advancing minimally invasive foot and ankle surgery.”